251 related articles for article (PubMed ID: 15306832)
1. Intensive insulin regimens: evidence for benefit.
Bretzel RG
Int J Obes Relat Metab Disord; 2004 Sep; 28 Suppl 2():S8-13. PubMed ID: 15306832
[TBL] [Abstract][Full Text] [Related]
2. Reducing cardiovascular disease risk in patients with type 2 diabetes and concomitant macrovascular disease: can insulin be too much of a good thing?
Rensing KL; Reuwer AQ; Arsenault BJ; von der Thüsen JH; Hoekstra JB; Kastelein JJ; Twickler TB
Diabetes Obes Metab; 2011 Dec; 13(12):1073-87. PubMed ID: 21736687
[TBL] [Abstract][Full Text] [Related]
3. Type 1 diabetes: benefits of intensive insulin therapy. Patients should control blood glucose strictly.
Prescrire Int; 2002 Apr; 11(58):61. PubMed ID: 11987320
[TBL] [Abstract][Full Text] [Related]
4. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
Dailey G
Clin Ther; 2011 Jun; 33(6):665-78. PubMed ID: 21704233
[TBL] [Abstract][Full Text] [Related]
5. [Insulin therapy].
Brunetti P
Minerva Endocrinol; 2001 Jun; 26(2):65-86. PubMed ID: 11479436
[TBL] [Abstract][Full Text] [Related]
6. Reducing hypoglycaemia with insulin analogues.
Heller S
Int J Obes Relat Metab Disord; 2002 Sep; 26 Suppl 3():S31-6. PubMed ID: 12174321
[TBL] [Abstract][Full Text] [Related]
7. Intensive insulin therapy in insulin-dependent diabetes mellitus, the results of the diabetes control and complications trial.
Duron F
Biomed Pharmacother; 1995; 49(6):278-82. PubMed ID: 7579008
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes.
Tandon N; Ali MK; Narayan KM
Am J Cardiovasc Drugs; 2012 Feb; 12(1):7-22. PubMed ID: 22217193
[TBL] [Abstract][Full Text] [Related]
9. Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitus.
Genuth S
Ann Intern Med; 1996 Jan; 124(1 Pt 2):104-9. PubMed ID: 8554200
[TBL] [Abstract][Full Text] [Related]
10. Issues surrounding tight glycemic control in people with type 2 diabetes mellitus.
Cerveny JD; Leder RD; Weart CW
Ann Pharmacother; 1998 Sep; 32(9):896-905. PubMed ID: 9762378
[TBL] [Abstract][Full Text] [Related]
11. [Indication of intensive insulin therapy and its practice].
Kishikawa H; Taguchi T; Matsumoto K; Shichiri M
Nihon Rinsho; 1999 Mar; 57(3):681-7. PubMed ID: 10199154
[TBL] [Abstract][Full Text] [Related]
12. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
[TBL] [Abstract][Full Text] [Related]
13. Micro- and macrovascular outcomes in Type 2 diabetic patients treated with insulin glulisine or human regular insulin: a retrospective database analysis.
Kress S; Kostev K; Dippel FW; Giani G; Rathmann W
Int J Clin Pharmacol Ther; 2012 Nov; 50(11):821-9. PubMed ID: 22578200
[TBL] [Abstract][Full Text] [Related]
14. Importance of controlling diabetes early--the concept of metabolic memory, legacy effect and the case for early insulinisation.
Ranjit Unnikrishnan I; Anjana RM; Mohan V
J Assoc Physicians India; 2011 Apr; 59 Suppl():8-12. PubMed ID: 21818992
[TBL] [Abstract][Full Text] [Related]
15. An update on the long-acting insulin analogue glargine.
Thisted H; Johnsen SP; Rungby J
Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):1-11. PubMed ID: 16867163
[TBL] [Abstract][Full Text] [Related]
16. Why, when and how to initiate insulin therapy in patients with type 2 diabetes.
Tibaldi J; Rakel RE
Int J Clin Pract; 2007 Apr; 61(4):633-44. PubMed ID: 17394436
[TBL] [Abstract][Full Text] [Related]
17. Intensive insulin therapy in patients with type 1 diabetes mellitus.
Switzer SM; Moser EG; Rockler BE; Garg SK
Endocrinol Metab Clin North Am; 2012 Mar; 41(1):89-104. PubMed ID: 22575408
[TBL] [Abstract][Full Text] [Related]
18. Diabetes technology and treatments in the paediatric age group.
Shalitin S; Peter Chase H
Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
[TBL] [Abstract][Full Text] [Related]
19. Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control.
Akalin S; Berntorp K; Ceriello A; Das AK; Kilpatrick ES; Koblik T; Munichoodappa CS; Pan CY; Rosenthall W; Shestakova M; Wolnik B; Woo V; Yang WY; Yilmaz MT;
Int J Clin Pract; 2009 Oct; 63(10):1421-5. PubMed ID: 19769698
[TBL] [Abstract][Full Text] [Related]
20. Effect of insulin therapy on macrovascular risk factors in type 2 diabetes.
Boyne MS; Saudek CD
Diabetes Care; 1999 Apr; 22 Suppl 3():C45-53. PubMed ID: 10189562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
